This session explores how to anticipate, prevent, and respond effectively to global health and security crises by strengthening pharmaceutical supply chains. It focuses on the strategic development, procurement, and stockpiling of medical countermeasures (MCM). Key topics include intelligence-driven risk mitigation, continuous manufacturing, adaptable production capacity, and coordinated international collaboration to secure rapid and equitable access to critical supplies. The session will also cover dual-use technologies and interoperable defense innovations and aims to unite experts from health, industry, research, and security to develop sustainable frameworks for future crises.

Process intensification combined with green and enabling synthetic technologies – including continuous manufacturing and flow chemistry – enables the production of APIs and critical intermediates in a safe and sustainable fashion. This approach supports the reshoring of critical medicines manufacturing to Europe.

Chair: C. Oliver Kappe

This session highlights innovative technologies, enabling new applications across oral, pulmonary, and other drug delivery routes. The focus is on how these emerging approaches drive flexibility, quality, and patient-centric solutions in pharmaceutical manufacturing.

Chair: Martin Spörk

This session explores the integration of advanced technologies into traditional oral drug product manufacturing, including digital tools, sustainable practices, and continuous processing. Emphasis is placed on practical adoption to enhance quality, resilience, and supply chain efficiency.

Chair: Stephan Sacher

Digital innovation and green strategies are transforming pharmaceutical manufacturing. Focus is on the integration of advanced analytics, AI, and GenAI with sustainable practices to drive efficiency, regulatory compliance, and environmental responsibility. Case studies illustrate how digitalization enables scalable, transparent, and resilient solutions for eco-friendly pharma production.

Chair: Gert Breitfuss

The integration of modeling and simulation are reshaping every stage of pharmaceutical product development – from research and development to production and supply chain optimization. The discussion will focus on how novel models are created and validated, what sets mechanistic and AI-driven approaches apart, and practical requirements for integrating these modeling tools into daily workflows. How can mechanistic and AI models be combined? And what does it take to approach regulatory drug filing supported by digital tools and predictions?

Chairs: Benedict Benque & Josip Matić